Daré Bioscience, Inc. (DARE) Ownership

NASDAQ: DARETop holders, insider trades and short interest.

DARE ownership summary

as of October 17, 2026
Institutions
13.4%
of shares outstanding
Insiders
11.72%
of shares outstanding
Shares outstanding
19.7M
Float
13.5M
shares available to trade
Short interest
4.71%
922K shares short
Days to cover
3.03
short interest up 7.3% vs prior month
  • Institutions 13.37%
  • Insiders 11.72%
  • Other investors 74.91%

DARE top institutional holders

20 largest
Daré Bioscience, Inc. top institutional holders
#Holder% of sharesSharesValueChangeReported
1Vanguard Capital Management, LLC3.26%641K$464,636+178,572 (+38.6%)June 30, 2026
2Geode Capital Management, LLC0.71%140K$101,567−37,746 (−21.2%)June 30, 2026
3U.S. Bancorp0.61%121K$87,667+29,550 (+32.3%)June 30, 2026
4Vanguard Fiduciary Trust Co0.46%91K$66,170+25,331 (+38.4%)June 30, 2026
5BlackRock Inc0.33%64K$46,580+47,277 (+278.6%)June 30, 2026
6State Street Corp0.24%47K$34,376+23,900 (+101.6%)June 30, 2026
7Jane Street Group LLC0.18%36K$26,167+36,092 (0.0%)June 30, 2026
8Northern Trust Corp0.17%34K$24,802+18,778 (+121.7%)June 30, 2026
9HRT FINANCIAL LLC0.11%22K$16,262+22,430 (0.0%)June 30, 2026
10Virtu Financial LLC0.08%16K$11,457+15,803 (0.0%)June 30, 2026
11LPL Financial Corp0.08%15K$10,795+250 (+1.7%)June 30, 2026
12T. Rowe Price Associates, Inc.0.07%13K$9,656+3,096 (+30.3%)June 30, 2026
13StoneX Group Inc0.06%11K$8,086+11,153 (0.0%)June 30, 2026
14Objectivity Squared LLC0.06%11K$7,913—June 30, 2026
15UBS Group AG0.03%6,810$4,937−36,553 (−84.3%)June 30, 2026
16Vanguard Global Advisers, LLC0.01%2,940$2,132—June 30, 2026
17Bay Harbor Wealth Management, LLC0.01%1,358$985+1,358 (0.0%)June 30, 2026
18IFS Advisors, LLC<0.01%950$689—June 30, 2026
19SBI Securities Co Ltd<0.01%645$468—June 30, 2026
20JONES FINANCIAL COMPANIES LLLP<0.01%396$287+396 (0.0%)June 30, 2026

Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 14 holders added 414K shares and 2 cut 74K.

DARE top mutual fund and ETF holders

8 largest
Daré Bioscience, Inc. top fund holders
#Holder% of sharesSharesValueChangeReported
1Vanguard MStar Total Stk Mkt Idx Invest2.40%471K$341,827—August 31, 2026
2Fidelity Extended Market Index0.45%89K$64,171+10,720 (+13.8%)August 31, 2026
3iShares Micro-Cap ETF0.22%43K$31,322−298 (−0.7%)September 30, 2026
4Fidelity Series Total Market Index0.12%23K$16,977—August 31, 2026
5Fidelity Total Market Index0.08%15K$11,111—August 31, 2026
6Vanguard Balanced Index Inv0.02%4,090$2,965−3,916 (−48.9%)August 31, 2026
71290 VT Micro Cap K0.02%2,978$2,159—August 31, 2026
8Vanguard U.S. Eq Idx £ Acc0.01%2,940$2,132—August 31, 2026

Funds report holdings monthly or quarterly; dates differ by fund.

DARE insider transactions

latest 20
Daré Bioscience, Inc. insider transactions
DateNameTransactionPriceSharesValue
2019-04-11Roger HawleyBuy$1.10454,545$500,000
2018-06-11Roger HawleyBuy$1.45140,000$203,000
2016-02-22David R WaltBuy$2.082,291$4,765
2016-02-18David R. WaltBuy$2.108,960$18,816
2016-02-16David R. WaltBuy$2.008,811$17,622
2016-02-11David R. WaltBuy$2.058,850$18,142
2016-02-09David R. WaltBuy$2.159,000$19,350
2016-02-05David R. WaltBuy$2.308,563$19,695
2016-02-03David R. WaltBuy$2.328,413$19,518
2016-02-01David R. WaltBuy$2.385,700$13,566
2016-01-28David R. WaltBuy$2.469,000$22,140
2016-01-26David R. WaltBuy$2.398,800$21,032
2016-01-25David R. WaltBuy$2.354,500$10,575
2016-01-22David R. WaltBuy$2.289,000$20,520
2016-01-20David R. WaltBuy$2.438,900$21,627
2016-01-15David R. WaltBuy$2.538,572$21,687
2016-01-13David R. WaltBuy$2.798,684$24,228
2016-01-11David R. WaltBuy$2.878,855$25,414
2016-01-07David R. WaltBuy$2.958,800$25,960
2016-01-05David R. WaltBuy$3.038,801$26,667

Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.

DARE shares outstanding

Shares outstanding

Year-end shares outstanding, adjusted for splits.

Who owns DARE

Institutional investors own 13.4% of Daré Bioscience's shares and insiders 11.72%. The largest holder is Vanguard Capital Management, LLC with 3.26% of the shares (641K), as of June 30, 2026. Among the top 20 institutions, 14 added shares and 2 reduced their stake in the latest filings. Short interest is 4.71% of the float, or 3.03 days of average trading volume. The share count rose 610.8% since 2014.

Related: DARE analyst forecast, DARE key metrics. See the DARE stock overview for the latest quote and news.

DARE ownership FAQ

Who owns the most Daré Bioscience stock?

The largest shareholders of Daré Bioscience are Vanguard Capital Management, LLC (3.26%), Geode Capital Management, LLC (0.71%), U.S. Bancorp (0.61%), Vanguard Fiduciary Trust Co (0.46%), BlackRock Inc (0.33%).

What percentage of Daré Bioscience is owned by institutions?

Institutions hold 13.4% of Daré Bioscience's shares outstanding; insiders hold 11.72%.

Which funds own Daré Bioscience?

The largest fund holders of Daré Bioscience are Vanguard MStar Total Stk Mkt Idx Invest (2.40%), Fidelity Extended Market Index (0.45%), iShares Micro-Cap ETF (0.22%), Fidelity Series Total Market Index (0.12%), Fidelity Total Market Index (0.08%).

What is Daré Bioscience's short interest?

922K shares of Daré Bioscience were sold short, 4.71% of the float; at the average daily volume it would take 3.03 days to cover.

Are insiders buying or selling Daré Bioscience?

Of the latest 20 reported insider transactions in Daré Bioscience (since January 5, 2016), 20 were purchases and 0 were sales.

How many shares of Daré Bioscience are outstanding?

Daré Bioscience has 19.7M shares outstanding, of which 13.5M are in the public float.

Biotechnology: ownership